Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole for Upper Abdominal Pain in sGERD
NCT00626535Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Mar 2003
- Primary completion
- Feb 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of esomeprazole in gastroesophageal reflux disease (GERD), sponsored by AstraZeneca. Started Mar 2003; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00626535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00626535.